Hypophosphatemic rickets linked to the X (XLH) chromosome - KRN 23 (burosumab) therapy: expert opinion of the Society for Metabolic Bone Diseases within the Czech Medical Association of J.E. Purkyně
Clinical Osteology · 2018
DOI: 10.36290/clo.2018.008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Osteology, 2018. Verfasst von Vladimír Palička und 3 weiteren Autor:innen. Die Arbeit nennt 22 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Palička, V., Bayer, M., Jan, R., & Kutílek, Š. (2018). Hypophosphatemic rickets linked to the X (XLH) chromosome - KRN 23 (burosumab) therapy: expert opinion of the Society for Metabolic Bone Diseases within the Czech Medical Association of J.E. Purkyně. Clinical Osteology. https://doi.org/10.36290/clo.2018.008
Vancouver
Palička V, Bayer M, Jan R, Kutílek Š. Hypophosphatemic rickets linked to the X (XLH) chromosome - KRN 23 (burosumab) therapy: expert opinion of the Society for Metabolic Bone Diseases within the Czech Medical Association of J.E. Purkyně. Clinical Osteology. 2018. doi:10.36290/clo.2018.008
BibTeX
@article{Palika2018,
author = {Palička, Vladimír and Bayer, Milan and Jan, Rosa and Kutílek, Štěpán},
title = {Hypophosphatemic rickets linked to the X (XLH) chromosome - KRN 23 (burosumab) therapy: expert opinion of the Society for Metabolic Bone Diseases within the Czech Medical Association of J.E. Purkyně},
journal = {Clinical Osteology},
year = {2018},
doi = {10.36290/clo.2018.008}
}
EUVIMED